» Articles » PMID: 32868346

Prevalence and Predictors of Oral to Intravenous Antibiotic Switch Among Adult Emergency Department Patients with Acute Bacterial Skin and Skin Structure Infections: a Pilot, Prospective Cohort Study

Overview
Journal BMJ Open
Specialty General Medicine
Date 2020 Sep 2
PMID 32868346
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To determine the prevalence and predictors of oral to intravenous antibiotic switch among adult emergency department (ED) patients with acute bacterial skin and skin structure infections (ABSSSIs).

Design: Multicentre, pilot cohort study.

Setting: Three urban EDs in Dublin, Ireland.

Participants: Consecutive ED patients aged >16 years old with ABSSSIs between March 2015 and September 2016.

Intervention: Oral flucloxacillin 500 mg-1 g four times a day (alternative in penicillin allergy).

Primary And Secondary Outcome Measures: The primary outcome was to determine the prevalence and predictors of oral to intravenous antibiotic switch. Secondary outcomes were to determine the prevalence and predictors of receiving an extended course of oral antibiotic treatment and measurement of interobserver reliability for clinical predictors at enrolment.

Results: Overall, 159 patients were enrolled of which eight were lost to follow-up and five were excluded. The majority of patients were male (65.1%) and <50 years of age (58.2%). Oral to intravenous antibiotic switch occurred in 13 patients (8.9%; 95% CI 4.8% to 14.7%). Increased lesion size (OR 1.74; 95% CI 1.09 to 2.79), white cell count (OR 1.32; 95% CI 1.05 to 1.67), athlete's foot (OR 8.00; 95% CI 2.31 to 27.71) and fungal nail infections (OR 7.25; 95% CI 1.99 to 26.35) were associated with oral to intravenous antibiotic switch. 24.8% (95% CI 18.1% to 33.0%) of patients received an extended course of oral antibiotic treatment.

Conclusion: The prevalence of oral to intravenous antibiotic switch in this pilot study is 8.9% (95% CI 4.8% to 14.7%). We identify the predictors of oral to intravenous switch worthy of future investigation.

Trial Registration Number: NCT02230813.

References
1.
Bouchiat C, Curtis S, Spiliopoulou I, Bes M, Cocuzza C, Codita I . MRSA infections among patients in the emergency department: a European multicentre study. J Antimicrob Chemother. 2016; 72(2):372-375. DOI: 10.1093/jac/dkw431. View

2.
Marwick C, Rae N, Irvine N, Davey P . Prospective study of severity assessment and management of acute medical admissions with skin and soft tissue infection. J Antimicrob Chemother. 2012; 67(4):1016-9. DOI: 10.1093/jac/dkr554. View

3.
Yadav K, Suh K, Eagles D, MacIsaac J, Ritchie D, Bernick J . Predictors of Oral Antibiotic Treatment Failure for Nonpurulent Skin and Soft Tissue Infections in the Emergency Department. Acad Emerg Med. 2018; 26(1):51-59. DOI: 10.1111/acem.13492. View

4.
Edelsberg J, Taneja C, Zervos M, Haque N, Moore C, Reyes K . Trends in US hospital admissions for skin and soft tissue infections. Emerg Infect Dis. 2009; 15(9):1516-8. PMC: 2819854. DOI: 10.3201/eid1509.081228. View

5.
Quirke M, Boland F, Fahey T, OSullivan R, Hill A, Stiell I . Prevalence and predictors of initial oral antibiotic treatment failure in adult emergency department patients with cellulitis: a pilot study. BMJ Open. 2015; 5(6):e008150. PMC: 4486970. DOI: 10.1136/bmjopen-2015-008150. View